×
About 2,295 results

ALLMedicine™ Vulvar Cancer Center

Research & Reviews  1,097 results

Development and validation of nomograms predicting cancer-specific survival of vulvar c...
https://doi.org/10.1002/ijgo.13722
International Journal of Gynaecology and Obstetrics: the ... Liu J, Wang M

Apr 26th, 2021 - To explore potential prognostic factors and develop nomograms to predict the cancer-specific survival of vulvar squamous cell carcinoma (SCC) and melanoma patients. Cases of vulvar SCC and melanoma were retrieved from the Surveillance, Epidemiolog...

Immediate lymphatic reconstruction: the time is right to prevent lymphedema following l...
https://doi.org/10.1136/ijgc-2021-002666
International Journal of Gynecological Cancer : Official ... Ince C, Temple-Oberle C et. al.

Apr 16th, 2021 - Immediate lymphatic reconstruction: the time is right to prevent lymphedema following lymphadenectomy for vulvar cancer.|2021|Ince C,Temple-Oberle C,Leitao MM,Coriddi M,Nelson G,|

Vulvar Adenocarcinoma of Intestinal Type: A Case Report of an Uncommon Entity.
https://doi.org/10.1097/PGP.0000000000000784
International Journal of Gynecological Pathology : Offici... Moscoso O, Reques A et. al.

Mar 30th, 2021 - Vulvar cancer is rare and accounts for only 5% of all gynecologic cancers. Squamous cell carcinoma is the most common and makes up 90% of the cases. Vulvar adenocarcinoma usually arises in Bartholin and other vulvar glands. Primary vulvar intestin...

Is it time to include 18FFDG-PET/CT in the diagnostic work-up for lymph node staging in...
https://doi.org/10.1007/s00259-021-05317-z 10.1097/igc.0000000000000975 10.1097/rlu.0000000000003411 10.1007/s00259-014-2689-7 10.1007/s00259-017-3740-2 10.1007/s00259-017-3727-z 10.1016/j.ejso.2017.06.018 10.1016/S1470-2045(10)70104-2 10.1007/s00259-019-04650-8
European Journal of Nuclear Medicine and Molecular Imaging; Aide N, Markovina S et. al.

Mar 26th, 2021 - Is it time to include 18FFDG-PET/CT in the diagnostic work-up for lymph node staging in cN0 vulvar cancer patients?|2021|Aide N,Markovina S,Ferrero A,|

Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients...
https://doi.org/10.1007/s10147-021-01862-7
International Journal of Clinical Oncology; Togami S, Kobayashi H et. al.

Mar 26th, 2021 - Sentinel lymph node (SN) biopsy is essential for evaluating survival and minimal treatment-related morbidity associated with cervical, endometrial, and vulvar cancer in Japan. As such, our aim in this study was to evaluate the current practice pat...

see more →

Guidelines  9 results

Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cance...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882649
International Journal of Clinical Oncology; Saito T, Tabata T et. al.

Nov 21st, 2017 - Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncology (JSGO) guidelines...

European Society of Gynaecological Oncology Guidelines for the Management of Patients W...
https://doi.org/10.1097/IGC.0000000000000975
International Journal of Gynecological Cancer : Official ... Oonk MHM, Planchamp F et. al.

Apr 25th, 2017 - The aim of this study was to develop clinically relevant and evidence-based guidelines as part of European Society of Gynaecological Oncology's mission to improve the quality of care for women with gynecologic cancers across Europe. The European S...

Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
https://doi.org/10.6004/jnccn.2017.0008
Journal of the National Comprehensive Cancer Network : JN... Koh WJ, Greer BE et. al.

Jan 3rd, 2017 - Vulvar cancer is a rare gynecologic malignancy. Ninety percent of vulvar cancers are predominantly squamous cell carcinomas (SCCs), which can arise through human papilloma virus (HPV)-dependent and HPV-independent pathways. The NCCN Vulvar Cancer ...

Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
http://www.jnccn.org/content/15/1/92.full
Koh, W.,et al

Dec 31st, 2016 - Vulvar cancer is a rare gynecologic malignancy. Ninety percent of vulvar cancers are predominantly squamous cell carcinomas (SCCs), which can arise through human papilloma virus (HPV)–dependent and HPV-independent pathways.

New NCCN Guidelines for Vulvar Cancer.
https://doi.org/10.6004/jnccn.2016.0184
Journal of the National Comprehensive Cancer Network : JN... Greer BE, Koh WJ

May 26th, 2016 - For the first time, NCCN Guidelines are available for vulvar cancer, a rare gynecologic cancer. Early-stage cancers can be managed by surgery and observation, and many of these patients can be cured. Lymph node status drives treatment and correlat...

see more →

Clinicaltrials.gov  1,139 results

Development and validation of nomograms predicting cancer-specific survival of vulvar c...
https://doi.org/10.1002/ijgo.13722
International Journal of Gynaecology and Obstetrics: the ... Liu J, Wang M

Apr 26th, 2021 - To explore potential prognostic factors and develop nomograms to predict the cancer-specific survival of vulvar squamous cell carcinoma (SCC) and melanoma patients. Cases of vulvar SCC and melanoma were retrieved from the Surveillance, Epidemiolog...

Immediate lymphatic reconstruction: the time is right to prevent lymphedema following l...
https://doi.org/10.1136/ijgc-2021-002666
International Journal of Gynecological Cancer : Official ... Ince C, Temple-Oberle C et. al.

Apr 16th, 2021 - Immediate lymphatic reconstruction: the time is right to prevent lymphedema following lymphadenectomy for vulvar cancer.|2021|Ince C,Temple-Oberle C,Leitao MM,Coriddi M,Nelson G,|

Vulvar Adenocarcinoma of Intestinal Type: A Case Report of an Uncommon Entity.
https://doi.org/10.1097/PGP.0000000000000784
International Journal of Gynecological Pathology : Offici... Moscoso O, Reques A et. al.

Mar 30th, 2021 - Vulvar cancer is rare and accounts for only 5% of all gynecologic cancers. Squamous cell carcinoma is the most common and makes up 90% of the cases. Vulvar adenocarcinoma usually arises in Bartholin and other vulvar glands. Primary vulvar intestin...

Is it time to include 18FFDG-PET/CT in the diagnostic work-up for lymph node staging in...
https://doi.org/10.1007/s00259-021-05317-z 10.1097/igc.0000000000000975 10.1097/rlu.0000000000003411 10.1007/s00259-014-2689-7 10.1007/s00259-017-3740-2 10.1007/s00259-017-3727-z 10.1016/j.ejso.2017.06.018 10.1016/S1470-2045(10)70104-2 10.1007/s00259-019-04650-8
European Journal of Nuclear Medicine and Molecular Imaging; Aide N, Markovina S et. al.

Mar 26th, 2021 - Is it time to include 18FFDG-PET/CT in the diagnostic work-up for lymph node staging in cN0 vulvar cancer patients?|2021|Aide N,Markovina S,Ferrero A,|

Survey of the clinical practice pattern of using sentinel lymph node biopsy in patients...
https://doi.org/10.1007/s10147-021-01862-7
International Journal of Clinical Oncology; Togami S, Kobayashi H et. al.

Mar 26th, 2021 - Sentinel lymph node (SN) biopsy is essential for evaluating survival and minimal treatment-related morbidity associated with cervical, endometrial, and vulvar cancer in Japan. As such, our aim in this study was to evaluate the current practice pat...

see more →

News  31 results

Leg lymphedema after gynecologic lymphadenectomy exceeds expectations
https://www.mdedge.com/familymedicine/article/164419/gynecologic-cancer/leg-lymphedema-after-gynecologic-lymphadenectomy
MDedge ObGyn; Mitchel L. Zoler

Apr 27th, 2018 - NEW ORLEANS – Leg lymphedema occurred in 19%-40% of women with a gynecologic cancer who underwent surgery with lymphadenectomy in a prospective study of 821 U. S.

Pelvic examination is essential to clinical care
https://www.mdedge.com/node/145629/path_term/49726

Sep 1st, 2017 - “THE PELVIC EXAM REVISITED” ERIN HIGGINS, MD, AND CHERYL B. IGLESIA, MD (AUGUST 2017) Pelvic examination is essential to clinical care I have contemplated the issue of the routine screening pelvic exam now for several years.

VIDEO: When early-stage vulvar cancer recurs, the prognosis is poor
https://www.mdedge.com/familymedicine/article/134754/gynecologic-cancer/video-when-early-stage-vulvar-cancer-recurs
Oncology Practice; Kari Oakes

Mar 30th, 2017 - NATIONAL HARBOR, MD – Cancer of the vulva is becoming more common, and as incidence is rising, so are death rates from the relatively rare malignancy. A new examination of women with early-stage vulvar cancer showed that recurrence was common, and.

Symptoms linger after ‘successful’ gyn. cancer therapy
https://www.mdedge.com/hematology-oncology/article/109733/gynecologic-cancer/symptoms-linger-after-successful-gyn-cancer
Bruce Jancin

Jun 19th, 2016 - SAN DIEGO – Fully half of gynecologic cancer survivors who are done with treatment and cancer free nonetheless report having moderate to severe symptoms 2 and even 5 years after diagnosis, Dr. Michelle Rowland reported at the annual meeting of the.

see more →

Patient Education  19 results see all →